Veradigm Management
Management criteria checks 2/4
Veradigm's CEO is Tom Langan, appointed in Jun 2024, has a tenure of less than a year. directly owns 0.2% of the company’s shares, worth $3.15M. The average tenure of the management team and the board of directors is 3.9 years and 6.5 years respectively.
Key information
Tom Langan
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.2% |
| Management average tenure | 3.9yrs |
| Board average tenure | 6.5yrs |
Recent management updates
Recent updates
Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price
Feb 28
Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger
Nov 10Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher
Mar 06Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?
Feb 13Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate
Jan 22These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well
Jan 04Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)
Dec 03Allscripts Healthcare reaffirms 2022 financial guidance; shares fall 2%
Sep 28Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?
Sep 17Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist
Aug 24We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt
Jul 31Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?
Jun 15CEO
Tom Langan (58 yo)
less than a year
Tenure
Mr. Thomas J. Langan, also known as Tom, serves as CEO of Veradigm Inc. since June 7, 2024. He served as President at Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc.) since May 06, 2...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 9.4yrs | US$303.00k | 0.044% $ 716.8k | |
| Senior VP of Marketing & Government Affairs | 4.5yrs | US$2.08m | 0.12% $ 1.9m | |
| Interim CEO | less than a year | no data | 0.20% $ 3.2m | |
| Interim CFO and Principal Financial & Accounting Officer | less than a year | no data | no data | |
| Vice President of Investor Relations | 3.9yrs | no data | no data | |
| Senior Vice President of Corporate Development & Strategy | 5.9yrs | no data | no data | |
| Senior VP & Chief Human Resources Officer | 3.6yrs | no data | 0.015% $ 236.5k | |
| Senior Vice President of U.S. Hospitals & Health Systems Sales | 10yrs | no data | no data | |
| Senior VP & General Manager for Classic Client Solutions Business Unit | 4.3yrs | no data | no data | |
| Senior Vice President of Global Client Delivery Organization | 2.9yrs | no data | no data | |
| President of Allscripts International | 7.9yrs | no data | no data | |
| Senior VP & Corporate Secretary | no data | no data | no data |
3.9yrs
Average Tenure
54yo
Average Age
Experienced Management: MDRX's management team is considered experienced (3.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman of the Board | 9.4yrs | US$303.00k | 0.044% $ 716.8k | |
| Independent Director | 8.6yrs | US$301.00k | 0.091% $ 1.5m | |
| Lead Independent Director | 4.3yrs | US$277.50k | 0.037% $ 601.6k | |
| Independent Director | 8.6yrs | US$281.50k | 0.032% $ 507.7k | |
| Member of Advisory Board | no data | no data | no data | |
| Independent Director | 4.5yrs | US$277.50k | 0.033% $ 537.8k | |
| Director | 1.8yrs | no data | 0.012% $ 200.1k | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data | |
| Member of Advisory Board | no data | no data | no data |
6.5yrs
Average Tenure
62.5yo
Average Age
Experienced Board: MDRX's board of directors are considered experienced (6.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/18 07:22 |
| End of Day Share Price | 2024/12/18 00:00 |
| Earnings | 2022/09/30 |
| Annual Earnings | 2021/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Veradigm Inc. is covered by 46 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jasper Hellweg | Argus Research Company |
| Gregory Bolan | Avondale Partners |
| Matthew Gillmor | Baird |